Associated with aging] weighed against non-pilots.

Commercial air line pilots are reported to be at an elevated risk for a few cancers, but research on the biological effects of their exposure to cosmic radiation have been limited, relating to background information in this article. Previous studies have shown that cataracts could be caused by contact with radiation, including a recently available research of astronauts showing a link of incidence of cataracts with space radiation at exposure levels much like those of commercial air line pilots. Related StoriesAAO announces start of new online reference to improve eye care for childrenASH study shows excessive smoking contributes to ongoing poverty in West MidlandsQuitting smoking cigarettes may delay secondary progressive MS onsetVilhjalmur Rafnsson, M.D., Ph.D., of the University of Iceland, Reykjavik, and colleagues conducted a case control research involved 445 men to determine whether employment mainly because a pilot is associated with lens opacification.Kaiser Family Foundation. Copyright 2008 Advisory Board Kaiser and Company Family members Foundation. All rights reserved.. Aeterna Zentaris submits macimorelin acetate NDA to FDA Aeterna Zentaris Inc.S. Food and Drug Administration for its ghrelin agonist, macimorelin acetate . Phase 3 data possess demonstrated that the compound has the potential to be the first orally-approved item that induces growth hormones release to evaluate adult growth hormone deficiency , with accuracy comparable to available intravenous and intramuscular tests procedures. Related StoriesImmune submits Bertilimumab IND application to FDA for treatment of Bullous PemphigoidHigh degrees of satiety hormone leptin contribute to coronary disease in obese individualsLatitude, summer months daylight exposure make difference in outcomes for kids treated with growth hormones David Dodd, President and CEO of Aeterna Zentaris, commented, The submission of the NDA to the FDA is usually another major milestone in our strategy to provide macimorelin acetate to advertise as the first approved oral item for AGHD evaluation.